Sign In
Buy IOVA
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
IOVA LAWSUIT: Lose Money on Iovance Biotherapeutics, Inc.? Contact BFA Law before July 14 Court Deadline
08:42am, Wednesday, 21'st May 2025
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) and certa
Class Action Lawsuit Filed: Iovance Biotherapeutics, Inc. (IOVA) - Join by July 14, 2025 - Contact Levi & Korsinsky
07:15am, Wednesday, 21'st May 2025
NEW YORK, NY / ACCESS Newswire / May 21, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
04:48am, Wednesday, 21'st May 2025
Resilient and growing. Those two descriptions definitely apply to the healthcare sector.
IOVA LAWSUIT ALERT: Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. Investors - Lead Plaintiff Deadline July 14, 2025
09:45pm, Tuesday, 20'th May 2025
NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
NEW YORK and NEW ORLEANS, May 20, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses
Down More Than 75% This Year, Should Investors Throw in the Towel on Iovance Biotherapeutics Stock?
09:10pm, Tuesday, 20'th May 2025
Entering trading this week, shares of Iovance Biotherapeutics (IOVA 4.10%) have crashed by nearly 78% since the start of the year. It has been an abysmal start to 2025 for a company that does possess
Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. (IOVA) Investors - Lead Plaintiff Deadline on July 14, 2025
05:30pm, Tuesday, 20'th May 2025
NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. (IOVA) Shareholders of Class Action Lawsuit and July 14, 2025 Deadline
05:00pm, Tuesday, 20'th May 2025
NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / WHY: New York, N.Y., May 20, 2025.
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Iovance Biotherapeutics, Inc. (IOVA) Investors of July 14, 2025 Deadline
04:00pm, Tuesday, 20'th May 2025
NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
Deadline Approaching: Iovance Biotherapeutics, Inc. (IOVA) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith
12:00pm, Tuesday, 20'th May 2025
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming July 14, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who pur
Securities Lawsuit Alert: Iovance Biotherapeutics, Inc. (IOVA) - Contact Levi & Korsinsky Before July 14, 2025
11:45am, Tuesday, 20'th May 2025
NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Contact Levi & Korsinsky by July 14, 2025 to Join Class Action Against Iovance Biotherapeutics, Inc. (IOVA)
11:00am, Tuesday, 20'th May 2025
NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal sec
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Iovance Biotherapeutics, Inc. - IOVA
09:00am, Tuesday, 20'th May 2025
NEW YORK , May 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA). Such investors are
